Work

KEYNOTE-365 Cohorts E and F: Phase 1b/2 Study of Pembrolizumab + Lenvatinib Combination Therapy in Patients With Adenocarcinoma Metastatic Castration-Resistant Prostate Cancer (mCRPC) or Treatment-Emergent Neuroendocrine mCRPC (t-NE)

Year: 2021
Type: other
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4248171223
Cites:
Cited by:
Related to: 10